Table: Cytori Cell Research Institute -Q1 group results

ADR Biomedical Holdings

10/08/2023 07:01

Aug 10 (Reuters)- 
             Cytori Cell Research Institute, Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to  
                Jun 30, 2023        Jun 30, 2022      Mar 31, 2024 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            472 mln             543 mln            1.79     
                 (-13.1 pct)         (+17.9 pct)      (-16.5 pct)  
  Operating     loss 137 mln        loss 162 mln      loss 21 mln  
  Recurring     loss 169 mln        loss 186 mln      loss 80 mln  
  Net           loss 161 mln        loss 287 mln      loss 30 mln  
  EPS          loss 18.07 yen      loss 32.21 yen    loss 3.44 yen 
  Ann Div                                NIL                       
  -Q2 div                                NIL                       
  -Q4 div                                NIL                       
  
  NOTE - Cytori Cell Research Institute, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T